Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,977 | 18,672 | 16,862 | 20,005 | 22,133 |
| Receivables | 20 | 20 | 20 | 20 | 126 |
| TOTAL | $17,380 | $19,211 | $17,298 | $20,525 | $22,712 |
| Non-Current Assets | |||||
| PPE Net | 8 | 11 | 12 | 14 | 15 |
| Intangibles | 49,266 | 49,266 | 49,266 | 49,266 | 49,266 |
| TOTAL | $49,274 | $49,277 | $49,278 | $49,280 | $49,281 |
| Total Assets | $66,654 | $68,488 | $66,576 | $69,805 | $71,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,146 | 1,284 | 1,245 | 2,315 | 1,930 |
| TOTAL | $2,146 | $1,284 | $1,245 | $2,315 | $1,930 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 201 | 1,628 | 1,141 |
| TOTAL | $612 | $2,312 | $2,513 | $3,940 | $3,453 |
| Total Liabilities | $2,758 | $3,596 | $3,758 | $6,255 | $5,383 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 16,274 | 15,474 | 14,129 | 13,829 | 13,829 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -228,480 | -227,302 | -224,987 | -224,049 | -220,687 |
| Other shareholders' equity | -6,038 | -6,038 | -6,038 | -6,038 | -6,038 |
| TOTAL | $63,896 | $64,892 | $62,818 | $63,550 | $66,610 |
| Total Liabilities And Equity | $66,654 | $68,488 | $66,576 | $69,805 | $71,993 |